The National Health Research Institutes and China Medical University jointly establish the Center for Collaborative Translational Research on Addiction

Date: September 27, 2011

Mental disorders and drug abuse have influenced public health and have consumed a large amount of social resources in many developed or developing countries globally. Mental disorders are complicated diseases and require various treatment methods by unique ethnic, cultural and regional factors. It is the rationale to collaborate multi-disciplinary researchers and clinicians to find out the optimal treatments for people in Taiwan and the global as well. Therefore, China Medical University (CMU) and the National Health Research Institutes (NHRI) have signed an agreement to jointly establish the Center for Collaborative Translational Research on Addiction (CCTRA). The CCTRA aims to promote the collaboration across the multi-disciplines including psychiatry and biomedicine for research and development. Through collaboratively and systematically exploring, researching, and developing psychiatric related behaviors, CCTRA could become the leader in the field not only in Taiwan but also in the world. 

CMU and CMU Hospital have been devoted themselves on treating drug addiction and related researches for years. The Center for Prevention of Drug Addiction in CMU Hospital (CPDA-CMUH) was the first funded facility among the medical centers for the purpose in Taiwan, with full-time specialists, including physicians, nurses and case managers. CPDA-CMUH is also served as the first national medical institute to perform methadone substitution therapy. In addition to providing methadone substitution therapy for the heroin-addicts, CPDA-CMUH offers inpatient and outpatient withdrawal therapies for alcohol and other drug addiction, and collaborates with several clinical departments in CMU hospital, including cardiology, gastroenterology, obstetrics and gynecology and inflectional diseases, to treat patients and to conduct researches. To date, patient volumes registered methadone substitution therapy program in CPDA-CMUH have counted as the top two among medical centers and top five among health care facilities in Taiwan covering the patients with HIV infection, those with a suspended prison sentence, and those with paying out-of-pocket. The achievements of CPDA-CMUH have been recognized and gained credits by the Health Authority in Taiwan.

The newly-established Center for Collaborative Translational Research on Addiction (CCTRA) will further incorporate the fundamental medicine researches and establish the specified wards to investigate the issue of addictions. We believe these initiatives will enhance new drug development, improve the psychosocial treatment modules, and broaden the applications for clinical cases in the future.

(Chinese Version.)


Signing Ceremony
Group Photo